John L. Brottem - 20 Mar 2023 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: General Counsel
Signature: John L Brottem
Issuer symbol: OM
Transactions as of: 20 Mar 2023
Net transactions value: -$72,572
Form type: 4
Filing time: 21 Mar 2023, 16:30:29 UTC
Previous filing: 16 Feb 2023
Next filing: 05 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Options Exercise	$13,414	+1,415	+2.2%	$9.48	65,727	20 Mar 2023	Direct	F1
transaction	OM	Common Stock	Sale	$29,460	-1,415	-2.2%	$20.82	64,312	20 Mar 2023	Direct	F2
transaction	OM	Common Stock	Sale	$56,526	-2,715	-4.2%	$20.82	61,597	20 Mar 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OM	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-1,415	-6.3%	$0.000000	21,218	20 Mar 2023	Common Stock	1,415	$9.48	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).
F2	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 17, 2023.
F3	This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.